130 related articles for article (PubMed ID: 25195010)
21. Inhibition of mitogen-activated protein kinase Erk1/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells.
Mulay V; Wood P; Manetsch M; Darabi M; Cairns R; Hoque M; Chan KC; Reverter M; Alvarez-Guaita A; Rye KA; Rentero C; Heeren J; Enrich C; Grewal T
PLoS One; 2013; 8(4):e62667. PubMed ID: 23634230
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α.
Kanaji N; Nelson A; Wang X; Sato T; Nakanishi M; Gunji Y; Basma H; Michalski J; Farid M; Rennard SI; Liu X
J Vasc Res; 2013; 50(2):145-56. PubMed ID: 23258237
[TBL] [Abstract][Full Text] [Related]
23. Formononetin-induced apoptosis of human prostate cancer cells through ERK1/2 mitogen-activated protein kinase inactivation.
Ye Y; Hou R; Chen J; Mo L; Zhang J; Huang Y; Mo Z
Horm Metab Res; 2012 Apr; 44(4):263-7. PubMed ID: 22328166
[TBL] [Abstract][Full Text] [Related]
24. A high throughput assay to identify substrate-selective inhibitors of the ERK protein kinases.
Miller CJ; Muftuoglu Y; Turk BE
Biochem Pharmacol; 2017 Oct; 142():39-45. PubMed ID: 28647489
[TBL] [Abstract][Full Text] [Related]
25. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway.
Liang FP; Lin CH; Kuo CD; Chao HP; Fu SL
J Biol Chem; 2008 Feb; 283(8):5023-33. PubMed ID: 18086662
[TBL] [Abstract][Full Text] [Related]
26. Induction of dissociated cytokine profiles by ISRAA with selective critical involvement of ERK1/2 in its signaling functions.
Elhannan S; Taha S; Ben Khalaf N; Bakheit H; Fathallah MD; Bakhiet M
Int J Mol Med; 2015 Dec; 36(6):1583-92. PubMed ID: 26499109
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
28. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
Moschos SJ; Sullivan RJ; Hwu WJ; Ramanathan RK; Adjei AA; Fong PC; Shapira-Frommer R; Tawbi HA; Rubino J; Rush TS; Zhang D; Miselis NR; Samatar AA; Chun P; Rubin EH; Schiller J; Long BJ; Dayananth P; Carr D; Kirschmeier P; Bishop WR; Deng Y; Cooper A; Shipps GW; Moreno BH; Robert L; Ribas A; Flaherty KT
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467321
[TBL] [Abstract][Full Text] [Related]
29. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells.
Bandyopadhyay G; Biswas T; Roy KC; Mandal S; Mandal C; Pal BC; Bhattacharya S; Rakshit S; Bhattacharya DK; Chaudhuri U; Konar A; Bandyopadhyay S
Blood; 2004 Oct; 104(8):2514-22. PubMed ID: 15226183
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
31. Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade.
Kang YH; Yang IJ; Shin HM
J Nat Med; 2012 Jan; 66(1):177-84. PubMed ID: 21833774
[TBL] [Abstract][Full Text] [Related]
32. Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.
Kim JB; Yang EY; Woo J; Kwon H; Lim W; Moon BI
In Vivo; 2020; 34(1):185-190. PubMed ID: 31882478
[TBL] [Abstract][Full Text] [Related]
33. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation.
Ohnishi H; Takeda K; Domenico J; Lucas JJ; Miyahara N; Swasey CH; Dakhama A; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):249-57. PubMed ID: 19130938
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of extracellular signal-regulated kinase 1/2 activity of the breast cancer cell line MDA-MB-231 leads to major alterations in the pattern of protein expression.
Seddighzadeh M; Linder S; Shoshan MC; Auer G; Alaiya AA
Electrophoresis; 2000 Jul; 21(13):2737-43. PubMed ID: 10949153
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells.
Arana-Argáez VE; Delgado-Rizo V; Pizano-Martínez OE; Martínez-Garcia EA; Martín-Márquez BT; Muñoz-Gómez A; Petri MH; Armendáriz-Borunda J; Espinosa-Ramírez G; Zúñiga-Tamayo DA; Herrera-Esparza R; Vázquez-Del Mercado M
J Biol Chem; 2010 Oct; 285(43):32824-32833. PubMed ID: 20729213
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
37. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway.
Li H; Tan J; Zou Z; Huang CG; Shi XY
Eur J Anaesthesiol; 2011 Jul; 28(7):525-34. PubMed ID: 21666544
[TBL] [Abstract][Full Text] [Related]
38. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology.
Boga SB; Alhassan AB; Cooper AB; Doll R; Shih NY; Shipps G; Deng Y; Zhu H; Nan Y; Sun R; Zhu L; Desai J; Patel M; Muppalla K; Gao X; Wang J; Yao X; Kelly J; Gudipati S; Paliwal S; Tsui HC; Wang T; Sherborne B; Xiao L; Hruza A; Buevich A; Zhang LK; Hesk D; Samatar AA; Carr D; Long B; Black S; Dayananth P; Windsor W; Kirschmeier P; Bishop R
Bioorg Med Chem Lett; 2018 Jun; 28(11):2029-2034. PubMed ID: 29748051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
